{"id":"glisolamide","rwe":[],"tags":[{"label":"glisolamide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"diabenor","offLabel":[],"synonyms":["glisolamide","diabenor","glysolamide"],"timeline":[],"approvals":[],"brandName":"Diabenor","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"glisolamide","explanation":"Think of it like a key that unlocks a door. In this case, the door is a process in the body that controls blood sugar levels. Diabenor is like a key that blocks the door, preventing the process from happening and helping to lower blood sugar levels.","oneSentence":"Diabenor works by inhibiting a specific enzyme or receptor involved in glucose regulation.","technicalDetail":"Glisolumamide is a small molecule inhibitor that targets a specific enzyme or receptor involved in glucose metabolism, although the exact molecular details of its mechanism of action are currently unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1304","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GLISOLAMIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T13:48:29.854315","biosimilars":[],"competitors":[],"genericName":"glisolamide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"F83U6T74XR","CHEBI":"CHEBI:135707","INN_ID":"4764","UMLSCUI":"C0061329","ChEMBL_ID":"CHEMBL2106775","KEGG_DRUG":"D02429","PUBCHEM_CID":"65713","MESH_SUPPLEMENTAL_RECORD_UI":"C018953"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":5,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Diabenor, also known as Glisolumamide, is a small molecule drug in the glisolamide class. Its exact target and mechanism of action are unknown, but it is believed to work by inhibiting a specific enzyme or receptor involved in glucose regulation. Diabenor's commercial status and approved indications are unclear, and it is not known whether it is patented or available as a generic. Further research is needed to fully understand its effects and potential uses. As a result, key safety considerations and pharmacokinetic properties, such as half-life and bioavailability, are also unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}